MARKET

AVTX

AVTX

Avalo Therapeutics Inc
NASDAQ
18.00
-0.16
-0.88%
After Hours: 18.00 0 0.00% 16:10 06/25 EDT
OPEN
18.17
PREV CLOSE
18.16
HIGH
18.69
LOW
17.89
VOLUME
1.69M
TURNOVER
--
52 WEEK HIGH
24.27
52 WEEK LOW
4.500
MARKET CAP
946.18M
P/E (TTM)
-3.0856
1D
5D
1M
3M
1Y
5Y
1D
Avalo Appoints Ron Philips To Its Board Of Directors; Abdakibart Phase 3 Set For H1 2027
NASDAQ · 1d ago
Avalo Therapeutics Adds Independent Director Ron Philip
TipRanks · 2d ago
Avalo Therapeutics appoints Ron Philip to board of directors
PUBT · 2d ago
AVALO THERAPEUTICS APPOINTS RON PHILIP TO BOARD OF DIRECTORS
Reuters · 2d ago
Press Release: Avalo Therapeutics Appoints Ron Philip to Board of Directors
Dow Jones · 2d ago
Weekly Report: what happened at AVTX last week (0615-0619)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 06/17 12:06
Avalo Therapeutics Price Target Maintained With a $58.00/Share by BTIG
Dow Jones · 06/17 08:53
More
About AVTX
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Its pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein). AVTX-009 is a humanized monoclonal antibody (IgG4) that binds to interleukin-1β (IL-1β) with high affinity and neutralizes its activity. IL- 1β is a central driver in the inflammatory process. Quisovalimab is a fully human monoclonal antibody (mAb), directed against human LIGHT (Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes). AVTX-008 is a fully human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein. AVTX-008 is differentiated by having specific binding to BTLA, with no binding to LIGHT or CD160.

Webull offers Avalo Therapeutics Inc stock information, including NASDAQ: AVTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVTX stock methods without spending real money on the virtual paper trading platform.